Representative immunoblots of HER3 and downstream signaling are depicted in Fig. 2D. As expected, we found that the PI3K/AKT pathway was predominantly activated in HER3+ breast cancer compared to HER3- breast cancer. Here, ERBB3 is linked to breast carcinoma.